Results 91 to 100 of about 13,547 (178)

Structural Heterogeneity of the Membrane-Interacting Region of the HIV-1 Envelope Glycoprotein. [PDF]

J Am Chem Soc
Majumder A, Voth GA.
europepmc   +1 more source

Genotypic and phenotypic characteristics of CXCR4-using transmitted/founder HIV-1 envelope glycoproteins. [PDF]

J Virol
Martres D, Montagné T, Pani S, Jeanne N, Armani-Tourret M, Requena M, Vellas C, Raymond S, Lorin V, Gallois Y, Puissant-Lubrano B, Mouquet H, Delobel P, Izopet J, Lagane B.   +14 more
europepmc   +1 more source

Characterization of full-length and cytoplasmic tail-truncated envelope glycoproteins incorporated into human immunodeficiency virus (HIV-1) virions and virus-like particles. [PDF]

J Virol
Anang S, Zhang S, Ennis A, Ding H, Deshpande A, Nguyen HT, Kappes JC, Sodroski JG.   +7 more
europepmc   +1 more source

HIV Envelope Protein gp41 [PDF]

, 2020
openaire   +1 more source

Genotypic challenges in implementing broadly neutralizing antibody-based long-acting HIV-1 therapies. [PDF]

Commun Med (Lond)
Tao K, Herschhorn A, Fera D, Lynch RM, Julg BD, Korber B, Shafer RW.   +6 more
europepmc   +1 more source

DNA electroporation of HIV Env elicits robust T cell responses and memory B cell responses with muted serum antibody levels that can be boosted with recombinant protein. [PDF]

Vaccine
De Rosa SC, Gravett RM, Hahn WO, Villaran M, Huang Y, Schmitzberger L, Montefiori D, Domin E, Tomaras GD, Heptinstall J, Seaton KE, Ferrari G, Ozorowski G, Ward AB, Lee WH, van der Maas L, Polakowski L, Frank I, Tieu HV, Kalams SA, Garcia NMG, Huang J, Ghosh S, Purwar M, Kulp D, Humeau L, Kwong PD, McElrath MJ, Corey L, Weiner D, HVTN 304 Study Team.   +30 more
europepmc   +1 more source

Decoding the glycan shield: Immune recognition and response to the HIV-1 envelope trimer. [PDF]

J Biol Chem
Nawaz FZ, Adams TM, Demirturk ME, Avci FY.   +3 more
europepmc   +1 more source

A Plug-in system for reprogramming the editing patterns of base editors. [PDF]

Nat Commun
Zhong C, Yu L, Zhao T, Shen X, Li Z, Zhu W, Hu Z, Tian R, Han Z, He D.   +9 more
europepmc   +1 more source

Nanobody-Based Bioconjugates as Potent and Broadly Active Inhibitors of HIV Entry. [PDF]

J Am Chem Soc
Saha SJ, Kumariya R, Davis PA, Tourtellott E, Doria-Rose N, Bewley CA, Cheloha RW.   +6 more
europepmc   +1 more source

N-Glycans modulate tilting of HIV-1 envelope glycoprotein. [PDF]

Nat Commun
Shehata M, Casalino L, Duquette M, Chen S, Flaherty A, Waller PM, Villa E, Amaro RE.   +7 more
europepmc   +1 more source